Evidence map›Paper›PMID 40355557›Full record

ArticleThe EMBO journal2025

Approaches to stable isotope tracing and in vivo metabolomics in the cancer clinic.

Brandon Faubert, Alpaslan Tasdogan

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Brandon FaubertDepartment of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA. bfaubert@bsd.uchicago.edu.ORCID http://orcid.org/0000-0002-2886-886X
Alpaslan TasdoganDepartment of Dermatology, University Hospital Essen & German Cancer Consortium (DKTK), Partner Site Essen, Germany. alpaslan.tasdogan@uk-essen.de.ORCID http://orcid.org/0000-0003-2543-852X

Funding

Identifying factors regulating cancer metabolism in vivoR00CA237724 · NCI · UNIVERSITY OF CHICAGO · PI FAUBERT, BRANDON · 2022 to 2024
$667k
Deutsche Forschungsgemeinschaft (DFG) 467788900EC | H2020 | PRIORITY 'Excellent science' | H2020 European Research Council (ERC) 101078355HHS | NIH | National Cancer Institute (NCI) R00CA237724NCI NIH HHS R00 CA237724
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cancer MetabolismIntraoperative Patient InfusionsStable Isotope Tracing

Identifiers

PMID40355557
PMCPMC12170854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.